MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Por Bond, G, Hirshfield, K, Kirchhoff, T, Alexe, G, Bond, E, Robins, H, Bartel, F, Taubert, H, Wuerl, P, Hait, W, Toppmeyer, D, Offit, K, Levine, A

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene (Proceedings of the National Academy of Sciences of the United States of America (... Por Atwal, G, Kirchhoff, T, Bond, E, Monagna, M, Menin, C, Bertorelle, R, Scaini, M, Bartel, F, Böhnke, A, Pempe, C, Gradhand, E, Hauptmann, S, Offit, K, Levine, A, Bond, G

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene (vol 106, pg 10236, 2009) Por Atwal, G, Kirchhoff, T, Bond, E, Monagna, M, Menin, C, Bertorelle, R, Scaini, M, Bartel, F, Boehnke, A, Pempe, C, Gradhand, E, Hauptmann, S, Offit, K, Levine, A, Bond, G

Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. Por Lenos, K, Grawenda, A, Lodder, K, Kuijjer, M, Teunisse, A, Repapi, E, Grochola, L, Bartel, F, Hogendoorn, P, Wuerl, P, Taubert, H, Cleton-Jansen, A, Bond, G, Jochemsen, A

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Por Bond, G, Hu, W, Bond, E, Robins, H, Lutzker, S, Arva, N, Bargonetti, J, Bartel, F, Taubert, H, Wuerl, P, Onel, K, Yip, L, Hwang, S, Strong, L, Lozano, G, Levine, A

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene. Por Atwal, G, Kirchhoff, T, Bond, E, Montagna, M, Monagna, M, Menin, C, Bertorelle, R, Scaini, M, Bartel, F, Böhnke, A, Pempe, C, Gradhand, E, Hauptmann, S, Offit, K, Levine, A, Bond, G